ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
체세포 유전자 검사 시장 규모는 최근 급성장하고 있습니다. 2025년 77억 8,000만 달러에서 2026년에는 88억 8,000만 달러에 이르고, CAGR 14.1%의 성장이 전망되고 있습니다. 지난 수년간의 성장 요인으로는 유전자 검사에 대한 접근성 제한, 기존 진단법에 대한 의존도, 암의 체세포 돌연변이에 대한 인식 증가, 병원 및 임상검사 시설 인프라 확충, 연구기관에 대한 투자 증가 등을 꼽을 수 있습니다.
체세포 유전자 검사 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 149억 2,000만 달러에 이르고, CAGR은 13.9%를 나타낼 전망입니다. 예측 기간 동안 성장 요인으로는 차세대 염기서열 분석(NGS) 및 멀티오믹스 기술의 발전, 재택 및 임상 염기서열 분석 서비스 확대, 정밀의료 이니셔티브 증가, 유전자 검사 프로그램에 대한 정부 자금 지원 증가, 돌연변이 해석을 위한 AI 기반 분석의 통합 등을 꼽을 수 있습니다. 등이 있습니다. 예측 기간의 주요 동향으로는 암 및 희귀질환을 위한 표적 유전자 패널 채택 확대, 차세대 염기서열 분석(NGS) 기술 활용 증가, 개인 맞춤형 정밀 암 치료의 성장, 재택 유전자 검사 솔루션 확대, 임상 의사결정을 위한 멀티오믹스 데이터 통합 등을 들 수 있습니다.
암 발생률의 급증은 체세포 유전자 검사 시장의 성장을 견인할 것으로 보입니다. 암은 비정상적인 세포가 체내에서 무질서하게 증식, 확산되는 질병군을 말합니다. 이러한 증가 추세는 영양부족, 흡연, 운동부족, 과도한 음주 등 생활습관 요인에 기인합니다. 체세포 유전자 검사는 종양 특이적 돌연변이를 확인하여 암 진단을 돕고, 정밀하고 맞춤화된 치료를 가능하게 합니다. 최첨단 기술을 통해 침습적 검사를 줄이고, 검출 신뢰도를 높이며, 환자에게 유익한 결과를 제공합니다. 예를 들어, 2023년 11월 캐나다에 본부를 둔 전국적인 암 단체인 캐나다 암 협회는 2023년 신규 진단 건수가 23만 9,100건, 사망자 수가 약 8만 6,700명에 달할 것으로 예측했습니다. 이처럼 암 발생률 증가가 체세포 유전자 검사 시장을 견인하고 있습니다.
체세포 유전자 검사 시장의 주요 기업들은 정확도 향상, 조기 발견, 침습적 방법의 회피 등을 목적으로 액체 생검 검사 등의 진단 도구 개발을 진행하고 있습니다. 액체생검 검사는 혈액 내 순환 종양 DNA(ctDNA)와 바이오마커를 비수술적으로 분석하여 암 관련 돌연변이를 검출하는 검사입니다. 예를 들어, 2024년 9월 인도에 본사를 둔 유전체 바이오인포매틱스 기업 스트랜드 생명과학(Strand Life Sciences)는 혈액에서 ctDNA 검출을 위한 최첨단 액체 생검인 '소매틱 어드밴티지 74 액체 생검(SA74 LB)' 검사를 도입했습니다. 차세대 염기서열분석(NGS) 기술을 이용한 검사로 74개 중요 암 유전자의 체세포 돌연변이를 분석합니다. 치료 가능한 돌연변이 확인, 치료 효과 추적, 조직 채취 없이 미세잔존병변(MRD) 검출을 통해 개인 맞춤형 암 치료를 실현합니다. 이 검사는 표적약물 선택 및 진행상황, 내성 모니터링의 실시간 평가에 활용됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
Somatic genetic testing involves the detailed analysis of genetic mutations that develop in non-reproductive (somatic) cells during a person's lifetime, most commonly in tumor tissues. This testing is essential in cancer diagnosis and treatment, as it identifies specific genetic alterations that can be targeted with personalized therapies, helping to predict disease progression and guide clinical decisions.
The main types of somatic genetic testing are targeted gene panels, whole exome sequencing, whole genome sequencing, carrier screening, and others. Targeted gene panels focus on analyzing a specific set of genes linked to a particular disease or condition, enabling precise and cost-effective diagnosis. Samples for testing include tissue-based, blood-based, bone marrow aspirates, and others, utilizing advanced technologies such as polymerase chain reaction (PCR), next-generation sequencing (NGS), microarray, Sanger sequencing, and more. This testing is applied in cancer diagnosis, cardiovascular disorders, neurological disorders, inherited genetic disorders, and other areas, serving end users such as hospitals, clinical laboratories, research institutes, at-home testing providers, and more.
Tariffs have impacted the somatic genetic testing market by increasing costs of imported sequencing instruments, reagents, and consumables used in PCR, NGS, and microarray technologies. Segments like whole genome sequencing and targeted gene panels are most affected, particularly in North America and Europe, which rely heavily on imported high-tech equipment. This has resulted in higher operational costs and potential delays in testing services. On the positive side, tariffs have encouraged local manufacturing, investment in domestic sequencing infrastructure, and development of cost-efficient testing solutions.
The somatic genetic testing market research report is one of a series of new reports from The Business Research Company that provides somatic genetic testing market statistics, including somatic genetic testing industry global market size, regional shares, competitors with a somatic genetic testing market share, detailed somatic genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the somatic genetic testing industry. This somatic genetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The somatic genetic testing market size has grown rapidly in recent years. It will grow from $7.78 billion in 2025 to $8.88 billion in 2026 at a compound annual growth rate (CAGR) of 14.1%. The growth in the historic period can be attributed to limited access to genetic testing, reliance on conventional diagnostic methods, growing awareness of somatic mutations in cancer, increasing hospital and clinical laboratory infrastructure, rising investment in research institutes.
The somatic genetic testing market size is expected to see rapid growth in the next few years. It will grow to $14.92 billion in 2030 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to advancements in ngs and multi-omics technologies, expansion of at-home and clinical sequencing services, increasing precision medicine initiatives, rising government funding for genetic testing programs, integration of ai-based analytics for mutation interpretation. Major trends in the forecast period include rising adoption of targeted gene panels for cancer and rare diseases, increasing use of next-generation sequencing (ngs) technologies, growth in personalized and precision oncology treatments, expansion of at-home genetic testing solutions, integration of multi-omics data for clinical decision-making.
The escalating cancer incidence is poised to drive the somatic genetic testing market forward. Cancer encompasses disorders defined by rampant, spreading abnormal cells throughout the body. This growing burden stems from lifestyle factors like suboptimal nutrition, tobacco use, lack of exercise, and heavy drinking. Somatic genetic testing supports cancer diagnosis by pinpointing tumor-specific mutations, facilitating precise, individualized therapies. It curbs invasive methods through cutting-edge tools, enhancing detection reliability and patient results. For example, in November 2023, the Canadian Cancer Society, a Canada-based national cancer organization, projected 239,100 new diagnoses and about 86,700 deaths in 2023. Thus, the rising cancer incidence is fueling the somatic genetic testing market.
Prominent companies in the somatic genetic testing market are advancing diagnostic tools like liquid biopsy tests to sharpen precision, enable early spotting, and sidestep invasive steps. Liquid biopsy tests offer non-surgical analysis of circulating tumor DNA (ctDNA) or biomarkers in blood to uncover cancer-linked mutations. For instance, in September 2024, Strand Life Sciences, an India-based genomics and bioinformatics firm, introduced the Somatic Advantage 74 Liquid Biopsy (SA74 LB) test, a state-of-the-art liquid biopsy for ctDNA detection from blood. This NGS-driven assay scans somatic alterations in 74 critical cancer genes. It empowers tailored oncology by flagging treatable mutations, tracking therapy effects, and spotting minimal residual disease (MRD) minus tissue sampling. The test guides targeted drugs and real-time progression or resistance surveillance.
In June 2023, Genomenon Inc., a US healthcare tech company, acquired Boston Genetics Inc. for an undisclosed sum. This merger amplifies Genomenon's goal to map the full human genome by fusing its AI-driven Mastermind platform with Boston Genetics' expert team, elevating genomic analysis for clinical testing and drug development. Boston Genetics Inc. is a US genomics firm expert in variant curation and annotation via specialist geneticists.
Major companies operating in the somatic genetic testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Exact Sciences Corp., ARUP Laboratories Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., MedGenome Labs Ltd., Caris Life Sciences Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Invivoscribe Inc., Centogene N.V., Circulogene Theranostics LLC.
North America was the largest region in the somatic genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the somatic genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the somatic genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The somatic genetic testing market consists of revenues earned by entities by providing services such as tumor profiling, biomarker identification, companion diagnostic testing, mutation analysis, and next-generation sequencing (NGS) for personalized cancer therapy selection and treatment monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The somatic genetic testing market also includes sales of testing kits, reagents, assay panels, sequencing instruments, software tools for data analysis, and laboratory consumables used in the detection and interpretation of somatic mutations. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Somatic Genetic Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses somatic genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for somatic genetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The somatic genetic testing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Type: Targeted Gene Panels; Whole Exome Sequencing; Whole Genome Sequencing; Other Testing Methods
2) By Sample: Tissue-Based; Blood-Based; Bone Marrow Aspirates; Other Samples
3) By Technology: Polymerase Chain Reaction (PCR); Next-Generation Sequencing (NGS); Microarray; Sanger Sequencing; Other Technologies
4) By Application: Cancer Diagnosis; Cardiovascular Disorders; Neurological Disorders; Other Applications
5) By End-User: Hospitals; Clinical Laboratories; Research Institutes; Other End-Users
2) By Whole Exome Sequencing: Diagnostic Whole Exome Sequencing; Clinical Research Whole Exome Sequencing; Population-Based Whole Exome Sequencing
3) By Whole Genome Sequencing: Clinical Whole Genome Sequencing; Research Whole Genome Sequencing; De Novo Whole Genome Sequencing; Cancer Whole Genome Sequencing
4) By Other Testing Methods: Copy Number Variation Testing; Mitochondrial Deoxyribonucleic Acid (DNA) Testing; Ribonucleic Acid (RNA) Sequencing; Epigenetic Testing
Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Agilent Technologies Inc.; Illumina Inc.; QIAGEN N.V.; Exact Sciences Corp.; ARUP Laboratories Inc.; Natera Inc.; Myriad Genetics Inc.; Fulgent Genetics Inc.; Invitae Corporation; NeoGenomics Laboratories Inc.; Guardant Health Inc.; MedGenome Labs Ltd.; Caris Life Sciences Inc.; Oxford Nanopore Technologies Ltd.; Pacific Biosciences of California Inc.; Invivoscribe Inc.; Centogene N.V.; Circulogene Theranostics LLC.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Rising Adoption Of Targeted Gene Panels For Cancer And Rare Diseases
4.2.2 Increasing Use Of Next-Generation Sequencing (NGS) Technologies
4.2.3 Growth In Personalized And Precision Oncology Treatments
4.2.4 Expansion Of At-Home Genetic Testing Solutions
4.2.5 Integration Of Multi-Omics Data For Clinical Decision-Making
5. Somatic Genetic Testing Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Clinical Laboratories
5.3 Research Institutes
5.4 At-Home Testing Providers
5.5 Biopharmaceutical Companies
6. Somatic Genetic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Somatic Genetic Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Somatic Genetic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Somatic Genetic Testing Market Size, Comparisons And Growth Rate Analysis
7.3. Global Somatic Genetic Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Somatic Genetic Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Somatic Genetic Testing Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Somatic Genetic Testing Market Segmentation
9.1. Global Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.8. Global Somatic Genetic Testing Market, Sub-Segmentation Of Whole Genome Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Clinical Whole Genome Sequencing, Research Whole Genome Sequencing, De Novo Whole Genome Sequencing, Cancer Whole Genome Sequencing
9.9. Global Somatic Genetic Testing Market, Sub-Segmentation Of Other Testing Methods, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Somatic Genetic Testing Market
12.1. China Somatic Genetic Testing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Somatic Genetic Testing Market
13.1. India Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Somatic Genetic Testing Market
14.1. Japan Somatic Genetic Testing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Somatic Genetic Testing Market
15.1. Australia Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Somatic Genetic Testing Market
16.1. Indonesia Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Somatic Genetic Testing Market
17.1. South Korea Somatic Genetic Testing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Somatic Genetic Testing Market
19.1. South East Asia Somatic Genetic Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Somatic Genetic Testing Market
20.1. Western Europe Somatic Genetic Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Somatic Genetic Testing Market
21.1. UK Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Somatic Genetic Testing Market
22.1. Germany Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Somatic Genetic Testing Market
23.1. France Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Somatic Genetic Testing Market
24.1. Italy Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Somatic Genetic Testing Market
25.1. Spain Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Somatic Genetic Testing Market
26.1. Eastern Europe Somatic Genetic Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Somatic Genetic Testing Market
27.1. Russia Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Somatic Genetic Testing Market
28.1. North America Somatic Genetic Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Somatic Genetic Testing Market
29.1. USA Somatic Genetic Testing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Somatic Genetic Testing Market
31.1. South America Somatic Genetic Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Somatic Genetic Testing Market
32.1. Brazil Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Somatic Genetic Testing Market
33.1. Middle East Somatic Genetic Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Somatic Genetic Testing Market
34.1. Africa Somatic Genetic Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Somatic Genetic Testing Market Regulatory and Investment Landscape
36. Somatic Genetic Testing Market Competitive Landscape And Company Profiles
